A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: sign (706), demonstration (32), expression (79), symptom (951), appearance (66)

Symptom and consequence: not interchangeable

Description
A court considers whether a patient with fluctuating capacity should be compelled to have haemodialysis at times when he refuses it
Url
/HealthProfessionals/Clinical-law-updates/Symptom-and-consequence-not-interchangeable.aspx

Prof Mike Grocott, research lead for lung injury and critical care

Description
NIHR Southampton Biomedical Research Centre Auto Generated Title Critical care consultant and researcher with a fo cus on hypoxia, lung injury
Url
/ClinicalResearchinSouthampton/Our-people/Respiratory-research-people/Mike-Grocott,-research-lead-for-lung-injury-and-critical-care.aspx

Compulsory treatment for diabetes

Description
The Court of Protection considers whether a patient should be treated for diabetes against his wishes.
Url
/HealthProfessionals/Clinical-law-updates/Compulsory-treatment-for-diabetes.aspx

Can the Mental Health Act enforce blood transfusion?

Description
A court considers whether a blood transfusion can be administered compulsorily under the Mental Health Act.
Url
/HealthProfessionals/Clinical-law-updates/Can-the-Mental-Health-Act-enforce-blood-transfusion.aspx

Restraining children

Description
To provide treatment for children, it is sometimes necessary to restrain them. How can this be done lawfully?
Url
/HealthProfessionals/Clinical-law-updates/Restrainingchildren.aspx

Bexarotene

Description
Chemotherapy Protocol Cutaneous T-cell Lymphoma BEXAROTENE Regimen • Cutaneous T-cell Lymphoma - Bexarotene Indication • Bexarotene is indicated for the treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bexarotene.pdf

Obinutuzumab_maintenance

Description
Chemotherapy Protocol Non-Hodgkin Lymphoma Obinutuzumab (Maintenance) Regimen • NHL – Obinutuzumab (Maintenance) Indication • Obinutuzumab in combination with bendamustine followed by obinutuzumab maintenance
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Obinutuzumab-maintenance.pdf

Deprivation of liberty in adults and children

Description
Governments encourage patients to believe they have choice, which may extend to the identity of their surgeon. Irrespective of whether this
Url
/HealthProfessionals/Clinical-law-updates/Deprivation-of-liberty-in-adults-and-children.aspx

Von Hippel-Lindau disease (VHL) - patient information

Description
Information about von Hippel-Lindau (VHL) disease.
Url
/Media/UHS-website-2019/Patientinformation/Genetics/Von-Hippel-Lindau-disease-VHL-1438-PIL.pdf

O-CVP-Cyclophosphamide-Obinutuzumab-Prednisolone-Vincristine

Description
Chemotherapy Protocol Non-Hodgkin Lymphoma Cyclophosphamide-Obinutuzumab-Prednisolone-Vincristine Regimen (O-CVP) • NHL – O-CVP-Cyclophosphamide-Obinutuzumab-Prednisolone-Vincristine Indication • Obinutuzumab
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/O-CVP-Cyclophosphamide-Obinutuzumab-Prednisolone-Vincristine.pdf
1 to 10 of 17
Previous 1 2 Next